The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function

European Journal of Immunology

Volumn 32, Issue 7, 2002, Pages 1969-1979

  Wang, Jing ^a   Foster, Amy ^a   Chin, Robert ^a   Yu, Ping ^a   Sun, Yonglian ^a   Wang, Yang ^a   Pfeffer, Klaus ^b   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibody response; Chemokine; LIGHT; LT receptor; Splenic structure

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN G; LIGHT PROTEIN; LYMPHOTOXIN; LYMPHOTOXIN BETA; LYMPHOTOXIN BETA RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; GERMINAL CENTER; HERPES VIRUS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHATIC SYSTEM; MICROENVIRONMENT; MOUSE; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SPLEEN; T LYMPHOCYTE; TRANSGENE;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; CHEMOKINES, CC; DENDRITIC CELLS, FOLLICULAR; GENETIC COMPLEMENTATION TEST; GERMINAL CENTER; LYMPH NODES; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; T-LYMPHOCYTES; TRANSGENES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036318880     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M     Document Type: Article

References (42)

1. Localization dose and time of antigens determine immune reactivity
2. Dendritic cells and the control of immunity
3. Chemokines and cell migration in secondary lymphoid organs
4. Roles of tumour localization, second signals and cross priming in cytotoxic T cell induction
5. Development and maturation of secondary lymphoid tissues
6. Lymphoid neo-organogenesis: Lymphotoxin's role in inflammation and development
7. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development
8. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface
9. Characterization of lymphotoxin-alpha-beta complexes on the surface of mouse lymphocytes
10. The ligands and receptors of the lymphotoxin system
11. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
12. Lymphotoxin-alpha-deficient mice: Effects on secondary lymphoid organ development and humoral immune responsiveness
13. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice
14. Distinct roles in lymphoid organogenesis for lymphotoxin α and β revealed in lymphotoxin β-deficient mice
15. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
16. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator
17. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer
18. Modulation of T cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway
19. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells
20. The regulation of T cell homeostasis and autoimmunity by T cell derived LIGHT
21. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
22. Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells
23. A B cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
24. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
25. Splenic T zone development is B cell dependent
26. Lymphotoxin-expressing B cells induce formation of splenic clusters of follicular dendritic cells
27. Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells
28. The role of lymphotoxin and type I TNF receptor in the formation of Germinal centers
29. Lymphotoxin-alpha (Lt-Alpha) supports development of splenic follicular structure that is required for IgG responses
30. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice
31. Cells in the marginal zone of the spleen
32. B cell subsets and the mature pre-immune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory"
33. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
34. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue
35. Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin
36. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
37. Insulin-dependent diabetes mellitus
38. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor
39. A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice
40. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway
41. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis
42. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues